Claris Ventures
Overview
Claris Ventures is an Italian venture capital firm focused on early-stage investments in high-potential biopharma companies, particularly those originating from the Italian research and development ecosystem.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sibylla Biotech | Oct 2022 | Series A | Co-investor |
| ALKemist Bio | Dec 2023 | Seed | Lead |
| IAMA Therapeutics | Apr 2025 | Series B | Co-investor |
| Kither Biotech | Mar 2022 | Series B | Lead |
| NeoPhore | May 2024 | Series B Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
Ciro Spedaliere
Founding Partner
Giulia Vestri
Partner
Pietro Puglisi
Partner
Paolo Vigo
Investment Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Claris Ventures based?
Claris Ventures is headquartered in Turin, Italy.
When was Claris Ventures founded?
Claris Ventures was founded in 2019.
How many portfolio companies does Claris Ventures have?
Claris Ventures has 8 portfolio companies in Caplight's dataset.
What are some companies in Claris Ventures's portfolio?
Portfolio companies visible on Caplight include Sibylla Biotech, ALKemist Bio, IAMA Therapeutics, Kither Biotech, NeoPhore.
What was Claris Ventures's most recent investment shown here?
Claris Ventures's most recent investment in this portfolio sample was in IAMA Therapeutics in 2025.
What sectors does Claris Ventures focus on?
Claris Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Claris Ventures focus on?
Claris Ventures typically invests at the Early stage.
What is Claris Ventures's AUM?
Claris Ventures's assets under management are estimated between $91.8M and $199.8M.